The vascular closure devices industry is in the midst of remarkable growth and transformation, evident both in its current market value and the expected trends. As of 2023, the market has surged to a valuation of approximately US$ 1,468.4 million, emphasizing the escalating demand for vascular closure devices.Lookin.
Haemonetics Corp. returned to the M&A trail with an agreement to buy Opsens Inc., a cardiology-focused medical device company, for CA$2.90 (US$2.13) per share for a total of CA$345 million (US$253 million). The all-cash transaction, its third significant purchase in five years, is expected to close by late January 2024, pending the approval of regulators and 66.66% of voting shareholders. Haemonetics expects the deal to be immediately accretive to adjusted earnings per share (EPS).
"The top five companies in this market are Terumo Corporation (Japan), Abbott (US), Cardinal Health (US), Cardiva Medical, Inc. (US), Medtronic Plc (Ireland), Morris Innovative, Inc. (US)"Terumo Corporation (Japan) is a